The UK's £2.5bn SMR Bet Is Industrial Policy, Not Energy Policy

In June 2025 the UK government selected Rolls-Royce as the industrial partner to Great British Energy-Nuclear on the country's small modular reactor programme, backed by £2.5 billion of state capital and a target of first commercial deployment by the mid-2030s. The choice came at the end of a two-year competitive process against Westinghouse Electric Company and a small number of other bidders. The official rationale focused on technology readiness; the underlying decision was a sovereign supply-chain call.

That distinction matters for how the equity case should be read. The UK is not investing £2.5 billion to lower the marginal cost of electricity by 2034 — there are faster and cheaper ways to do that. It is investing to position a domestic prime contractor at the front of a global SMR market that the International Atomic Energy Agency expects to enter commercial scale over the second half of the decade.

What the UK Is Actually Underwriting

The energy security argument is real but secondary. Domestic UK gas storage capacity is structurally low and EU spot prices remain elevated relative to the pre-2021 baseline. SMRs offer a path back to domestic baseload generation that reduces sensitivity to import dynamics. None of that justifies a £2.5 billion sovereign capital allocation on a 2034 timeline, however; conventional renewables and grid upgrades would deliver the same result faster.

The industrial argument is the one that does justify the spend. Rolls-Royce is the only UK-listed company with a credible nuclear manufacturing base — built up over decades of work on Royal Navy submarine reactors — capable of taking a modular reactor design from drawing to commercial deployment. Westinghouse, the US-controlled alternative, would have delivered the same technology with the same compliance profile, but the manufacturing supply chain and the export pipeline would have sat in Pennsylvania, not Derby. The £2.5 billion is, in effect, the cost of keeping the value chain onshore.

The Export Pipeline Is the Equity Story

A UK-only SMR programme cannot recover the development cost. The financial case for the Rolls-Royce investment relies on selling the same modular reactor design into multiple sovereign customers. Two early indicators of whether that works are already public.

First, in 2024 Rolls-Royce reached an agreement with ČEZ — Czechia's largest public utility — to deliver the country's first SMR. ČEZ is a credible sovereign-backed counterparty with an existing nuclear operating base, and the contract is the closest thing the programme has to a reference customer.

Second, since 2017 Rolls-Royce and the Jordan Atomic Energy Commission have been working through a memorandum of understanding that contemplates pairing SMR generation with seawater desalination to supply Amman. Jordan would be a more difficult financing case — sovereign capacity is thinner and the project requires multilateral support — but if it converts, it establishes the template for SMR deployment in water-scarce middle-income markets where the addressable demand for combined power-and-desalination is substantial.

Both opportunities convert to binding contracts no earlier than the late 2020s. The export pipeline is therefore a multi-year option that the listed equity does not currently price.

Why This Could Fail

Three failure modes are identifiable, and investors should be honest about which ones are material.

The first is cost. The £2.5 billion is initial capital and explicitly does not cover the full programme through commercial deployment. The track record on first-of-a-kind nuclear builds is uniformly poor — Hinkley Point C is currently running roughly five years late and approximately 40% over its original budget. Modular construction is supposed to address this, but the supposition is unproven at commercial scale.

The second is timeline. The first UK SMR is targeted for the mid-2030s. Two of the demand drivers used to underwrite the programme — AI data centre capacity and UK industrial electrification — are acute now. By the time the first reactor is energised, hyperscalers will have absorbed their demand through gas, restarted legacy nuclear and grid expansion. The SMR programme may arrive after the demand spike it was designed to serve.

The third is the competitive reference point. China National Nuclear Corporation's Linglong-1 begins commercial operation in the first half of 2026 — the first SMR in the world to clear IAEA safety review and a working reference design that emerging-market sovereigns can evaluate today, in production, against a UK programme that will be a paper specification for the next decade. The UK is not competing for the global SMR market against the US; it is competing against a Chinese reactor that already exists.

Our View

The UK's SMR programme is a credible industrial bet with a long payoff window. The listed-equity expression — Rolls-Royce — sits on a defensible underlying business (civil aerospace flying hours, defence and Power Systems) and is not dependent on the SMR programme to clear its operating thresholds. That means investors can size SMR exposure through the name without taking on pure-play technology risk.

We would not, however, treat the SMR programme as a near-term catalyst. The earliest decision point for the equity is the Czechia conversion to a binding offtake, which we expect over the next 18 to 24 months. Until then, the SMR optionality is a long-duration call attached to the existing aerospace and defence business — meaningful at scale but not the reason to own the shares today.

Educational information only. This is not personal financial advice.